CLINICAL_TRIALS
trial_result
· 2021-12-14
Clinical Trial Update: Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) [Phase 2, Phase 3]
Summary
Clinical trial update comparing Nova22007 to vehicle in vernal keratoconjunctivitis (phase 2/3) with completed status and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santen SAS | Conditions: Conjunctivitis, Vernal | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-12-14